[Form 4] Concentrix Corporation Insider Trading Activity

Rhea-AI Filing Summary

Concentrix Corp (CNXC) reporting person Cormac J. Twomey, EVP Global Ops & Delivery, reported a sale of 500 shares of Common Stock on 08/29/2025 at a price of $50.25 per share. After the sale, the reporting person beneficially owned 36,630 shares. The filing states the sale was executed pursuant to a Rule 10b5-1 trading plan established on January 28, 2025.

The Form 4 is signed by an attorney-in-fact and indicates this was a planned disposition rather than an ad hoc trade. No derivative transactions or other changes in holdings are reported.

Positive

• Sale executed under a Rule 10b5-1 trading plan, providing documented pre-approval and affirmative defense
• Complete disclosure of transaction details including price, date, and post-transaction holdings

Negative

• Insider disposed of 500 shares, reducing direct holdings to 36,630 shares

Insights

Securities Analyst

TL;DR Insider sold a small number of shares under a pre-established Rule 10b5-1 plan; holdings remain substantial at 36,630 shares.

The transaction appears routine: 500 shares were disposed of at $50.25 under a 10b5-1 plan, which provides an affirmative defense against insider trading claims by documenting prearranged sales. The residual holding of 36,630 shares indicates continued ownership and alignment with company performance, while the transaction size is small relative to typical insider holdings and unlikely to be material to the company or market.

Corporate Governance Expert

TL;DR Governance disclosure is clear: sale executed under an established 10b5-1 plan and properly reported on Form 4.

The filing discloses the required elements: reporting person identity, relationship to issuer, transaction date, number of shares sold, price, post-transaction ownership, and an explanation that the sale was pursuant to a Rule 10b5-1 plan dated January 28, 2025. The attorney-in-fact signature is provided, meeting execution formalities. There are no red flags such as unexplained large disposals or concurrent derivative activity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Twomey Cormac J

(Last) (First) (Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK CA 94560

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Ops & Delivery

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		S(1)		500	D	$50.25	36,630	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale was effected pursuant to a Rule 10b5-1 trading plan by the reporting person on January 28, 2025.

Remarks:

	/s/ Andrew A. Farwig, Attorney-in-Fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CNXC insider Cormac Twomey report on Form 4?

The filing shows a sale of 500 shares on 08/29/2025 at $50.25 per share; post-sale beneficial ownership is 36,630 shares.

Was the sale by the CNXC insider part of a prearranged plan?

Yes. The sale was effected pursuant to a Rule 10b5-1 trading plan established on January 28, 2025.

Does the Form 4 report any option exercises or derivative transactions for CNXC?

No. The filing includes only a non-derivative sale of common stock and reports no derivative securities.

Who signed the Form 4 for the reporting person?

The form is signed by Andrew A. Farwig, Attorney-in-Fact on 09/02/2025.

How material is this insider sale to CNXC shareholders?

The filing shows a relatively small sale of 500 shares and does not indicate material impact; the expert rating is neutral.